Compare Twist Bioscience Corp (TWST) vs Xylem, Inc. (XYL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Twist Bioscience Corp vs Xylem, Inc. — how do they compare? Twist Bioscience Corp trades at $88.31 (market cap $5.45B), while Xylem, Inc. trades at $120.79 (market cap $28.67B). The key difference: Xylem, Inc. is far larger — about 5.3× Twist Bioscience Corp's market cap, and Xylem, Inc. pays a 1.43% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| TWST | XYL | |
|---|---|---|
Market Cap | $5.45B | $28.67B |
Sector | Health | Industrials |
52-Week High | $102.88 | $152.95 |
52-Week Low | $24.16 | $106.34 |
Enterprise Value | $5.37B | $29.92B |
Dividend Yield | — | 1.43% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →
